Why the study?
Growth differentiation factor 15 is an emerging cardiovascular biomarker with a recently available automated immunoassay, but its determinants, reference intervals, and within-subject biological variation needed evaluation.
Population
533 presumably healthy questionnaire-screened adults
Design
Observational cross-sectional and biological variation study
Authors
Loading...
Provides GDF-15 reference intervals from healthy adults; leaves open validation before clinical adoption.
The study establishes a robust upper reference limit of 866 ng/L for serum GDF-15 in adults and demonstrates low intraindividual variation, supporting its use in longitudinal clinical monitoring.
Krintus et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: